Detecting Blockchain Investments with A.I.

The Innovation Shares NextGen Protocol ETF "KOIN" will be the first to use artificial intelligence to identify and invest in blockchain innovators. Matt Markiewicz, Managing Director at Innovation Shares, explained how the company leverages the emerging technology for portfolio management. Taking a traditional analytical approach is challenging for picking stocks based on thematic investing. By using machine learning, he says the company is able to uncover securities that may not be obvious to researchers because themes aren't found in financial statements. Markiewicz added that there is good potential for A.I. to replace analysts. Several companies have announced the implementation of blockchain or cryptocurrency into their name. Sometimes it has been suspicious. Markiewicz said the rules-based approach of the company prevents those types of stocks from finding their way into the portfolio.

More In Business

The Economic ‘Pain’ Fed Chief Jerome Powell Warned About Is Here

Data shows the economy grew less than expected in the first three months of the year, as consumers became more price conscious and spent less.

Will Live Nation and Ticketmaster Actually Be Broken Up?

The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!

The Future of Ether ETFs After That SEC Ruling

CoinShares CEO, Jean-Marie Mognetti, joins Cheddar to discuss what's next for ether ETFs and other cryptocurrency after the SEC surprise ruling.

The Trending, Fastest-Growing Summer Destinations Will Surprise You

From the Vegas strip to breathtaking national parks, we’re obsessed.

Nvidia's Blockbuster Run Is Just Getting Started

Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.

Perspective Therapeutics Is Creating New Ways to Fight Cancer

In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d

When It Comes to the Economy, There’s ‘A Lot to Be Optimistic About’

Business is booming, interest rate cuts aren’t desperately needed, and, consumers are in what one analyst calls ‘pretty good shape.’

More People Are Making 'no-buy year' Pledges. Should You?

The self-imposed rules of a no-buy challenge are simple: participants pledge to stop buying non-essential items.

Forget Inflation: American Consumers Want Travel and Experiences

Americans may be exhausted by inflation, but they aren't holding back when to comes to spending on travel and experiences.

The U.S. Can Avoid a Recession – But Higher Prices Are Here to Stay

Companies like Target, Walmart, and Amazon may be cutting prices – but consumers should get used to paying more than they did pre-pandemic.

Load More